|
Volumn 33, Issue 2, 2001, Pages 483-484
|
Clinical studies with silymarin: Fibrosis progression is the ned point [5]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
SILYMARIN;
DISEASE COURSE;
FIBROSIS;
LETTER;
PRIORITY JOURNAL;
CHOLAGOGUES AND CHOLERETICS;
DISEASE PROGRESSION;
DRUG THERAPY, COMBINATION;
FIBROSIS;
HUMANS;
LIVER CIRRHOSIS, BILIARY;
PROTECTIVE AGENTS;
RETREATMENT;
SILYMARIN;
URSODEOXYCHOLIC ACID;
|
EID: 0035146058
PISSN: 02709139
EISSN: None
Source Type: Journal
DOI: 10.1053/jhep.2001.22340 Document Type: Letter |
Times cited : (14)
|
References (16)
|